Cook Medical - Reproductive Health Portfolio
Cook Medical's Reproductive Health Portfolio manufactured assisted reproductive technology medical devices — including the MINC+ benchtop incubator, culture media, and embryo transfer/manipulation devices — serving IVF clinics and fertility centers via direct sales and distribution across Asia-Pacific markets.
- Company typePrivate
- Founded1963
- HeadquartersBloomington, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Cook Medical - Reproductive Health Portfolio does
Cook Medical's Reproductive Health Portfolio was a product line within Cook Medical that manufactured and distributed assisted reproductive technology (ART) medical devices for fertility, gynecology, and fertilization procedures. The portfolio served IVF clinics and fertility centers globally, with a particularly concentrated commercial footprint across Asia-Pacific markets served through ten wholly-owned regional subsidiaries and the ISO 13485:2016-certified Singapore Asia Distribution Centre. The portfolio was divested by Cook Medical on two occasions — first to CooperCompanies in February 2022, and subsequently to Astorg in 2024/2025, where the line was combined with Hamilton Thorne to form an integrated ART platform.
The portfolio's flagship product was the MINC+ Benchtop Incubator, a next-generation benchtop incubator offering 50% greater capacity than the original MINC, independently humidified chambers to reduce culture media evaporation, and the integrated DishTrace platform for dish-data management and monitoring across up to 50 incubators. The broader product suite comprised the legacy MINC Mini Incubator (a more than 20-year IVF clinic standard), culture media products, and devices for ovum aspiration, intrauterine insemination, and embryo transfer and manipulation. The MINC brand heritage, paired with physician-driven product development, gave the portfolio a multi-decade installed base in clinical embryology.
Cook Medical sold reproductive health products through direct regional sales teams and distribution partners, primarily across Asia-Pacific, using a hardware sales model with quote-based pricing rather than publicly disclosed rates. Marketing and clinician enablement were delivered through the Vista Education & Training platform, medical conferences, and physician education programs. As a privately held, family-owned business under Cook Group, the Reproductive Health Portfolio operated without public revenue disclosure.
Cook Medical - Reproductive Health Portfolio firmographics
Firmographics- Name
- Cook Medical - Reproductive Health Portfolio
- Legal name
- Cook Medical
- Website
- https://cookmedical.com
- Company type
- Private
- Founded year
- 1963
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Cook Medical's Reproductive Health Portfolio manufactured assisted reproductive technology medical devices — including the MINC+ benchtop incubator, culture media, and embryo transfer/manipulation devices — serving IVF clinics and fertility centers via direct sales and distribution across Asia-Pacific markets.
- Ownership category
- akta.pro rank
Cook Medical - Reproductive Health Portfolio industry classification
Industry- Product category
- IVF and Assisted Reproductive Technology Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
Keywords
Where Cook Medical - Reproductive Health Portfolio is headquartered
LocationHeadquarters
- HQ city
- Bloomington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Cook Medical - Reproductive Health Portfolio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Reproductive Health Medical Devices: Sale of assisted reproductive technology devices including MINC+ Benchtop Incubator, culture media, and devices for ovum aspiration, intrauterine insemination, and embryo transfer and manipulation.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Cook Medical - Reproductive Health Portfolio product offering
Product offeringCore offering
Cook Medical's Reproductive Health portfolio designed, manufactured, and sold assisted reproductive technology (ART) medical devices for IVF clinics and fertility centers. Core products included the MINC+ Benchtop Incubator (next-generation benchtop incubator with enhanced humidification and dish-tracking software), culture media, and devices for ovum aspiration, intrauterine insemination, and embryo transfer and manipulation. Sales were executed through regional sales teams and distribution partners serving Asia-Pacific markets.
Product overview
Cook Medical is a medical device company specializing in minimally invasive procedures across multiple clinical specialties. Note: Cook Medical sold its Reproductive Health/ART portfolio to Astorg (combined with Hamilton Thorne) in 2024. The remaining portfolio includes: (1) ART/IVF Products - MINC+ Benchtop Incubator (next generation with 50% larger capacity, humidified chambers, DishTrace monitoring), MINC Mini Incubator (20+ years standard), culture media, ovum aspiration devices, intrauterine insemination devices, and embryo transfer devices. (2) Vascular Products - Zilver PTX Drug-Eluting Peripheral Stent (paclitaxel-coated), Zilver Vena Venous Stent, Zenith Alpha Thoracic Endovascular Graft. (3) Urology Products - Resonance Metallic Ureteral Stent, Black Silicone Stents, Nitinol Stone Extractors including NCircle tipless basket, LithAssist suction control device, BIGopsy, holmium laser systems (Litho Magneto 150, Rhapsody H-30). (4) iMRI Division - Interventional MRI Suite platform (Siemens Healthineers partnership), Copernicus training, guided therapies, cardiac/vascular, oncology modules. (5) Other - EchoTip Insight pressure measurement, Biodesign Otologic Repair Grafts, Compass BDS Biliary Stents.
Differentiator
Problem solved
Functional benefit
Products and services
- MINC+ Benchtop Incubator Next generation benchtop incubator for IVF clinics with 50% larger capacity than previous MINC model, independently humidified chambers to reduce culture media evaporation, and integrated DishTrace platform providing dish-data management, culture dish tracking during check-in/out, and graphical history reports for up to 50 incubators.
- MINC Mini Incubator Original benchtop incubator established as a standard component in IVF clinics for more than 20 years; served as the foundation for the next-generation MINC+ design.
- Culture Media (IVF) Culture media products used in IVF procedures as part of Cook Medical's assisted reproductive technology (ART) product suite for embryo culture and development.
- Ovum Aspiration Devices Devices designed for ovum (egg) aspiration procedure in IVF treatments, part of Cook Medical's assisted reproductive technology portfolio.
- Intrauterine Insemination Devices Devices for intrauterine insemination procedures used in fertility treatment, part of Cook Medical's assisted reproductive technology product suite.
- Embryo Transfer and Manipulation Devices Devices for embryo transfer and manipulation procedures during IVF treatment, included in Cook Medical's assisted reproductive technology product portfolio.
Companies that use Cook Medical - Reproductive Health Portfolio
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Cook Medical - Reproductive Health Portfolio technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Cook Medical - Reproductive Health Portfolio partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered major divestiture.
- Astorgmajor divestitureCook Medical signed a letter of intent with Astorg to sell the IVF/ART product lines. Astorg, an investment firm with experience in MedTech manufacturing and product businesses, acquired and combined the Cook ART portfolio with Hamilton Thorne.
- CooperCompaniesmajor divestitureCook Medical Reproductive Health business was acquired by CooperCompanies, combining Cook's ART products with CooperSurgical's fertility portfolio.
Scale indicators9 records
Recent moves7 records
Expansion highlights5 records
Cook Medical - Reproductive Health Portfolio competitors and assessment
Company assessmentDirect peers
- Hamilton Thorne: Precision instruments, consumables, software, and services provider for the ART research and cell biology space; combined with Cook ART under Astorg in 2024/2025, making it the closest direct comparable and now the portfolio's sister entity.
- Vitrolife: Global ART media and device company offering culture media, time-lapse incubators, and consumables; competes head-to-head with Cook ART across the IVF workflow and is the largest single ART pure-play.
- CooperSurgical: Fertility and women's health division of CooperCompanies; initially acquired Cook Medical's Reproductive Health business in 2022 before divesting it to Astorg, and remains a direct competitor across IVF consumables and devices.
- Genea Biomedx: ART device innovator spun out of Genea, producing time-lapse incubators (Geri), benchtop devices, and lab automation; directly competes with the MINC+ on the incubator side of the IVF lab.
- Esco Medical: Specialist manufacturer of ART incubators (MIRI series) and related lab equipment; competes with Cook ART in the benchtop incubator category with a strong global installed base.
- FUJIFILM Irvine Scientific: Leading ART and cell culture media supplier now under FUJIFILM; competes directly with Cook ART's culture media line and increasingly offers complementary lab devices.
- Kitazato Corporation: Japan-based ART device and media company with global distribution, offering cryopreservation, ICSI, and embryo transfer products that overlap with Cook ART's portfolio.
- Rocket Medical: UK-based manufacturer of reproductive health and fertility devices including embryo transfer catheters and IUI catheters; competes with Cook ART in single-use procedural devices.
Broad incumbents
- Merck KGaA (Sigma-Aldrich): Diversified life sciences giant supplying ART-grade chemicals, media components, and lab tools to IVF clinics and research labs; broader portfolio but overlapping consumables customer base.
- Smiths Medical: Large diversified medical device manufacturer with presence in reproductive health and adjacent minimally invasive device categories; comparable as a broad-incumbent peer for the procedural side of the ART portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Cook Medical - Reproductive Health Portfolio social profiles
Digital presenceCook Medical - Reproductive Health Portfolio compliance and trust
Trust signalCompliance3 records
Cook Medical - Reproductive Health Portfolio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cook Medical - Reproductive Health Portfolio leadership team
Management profileNumber of profiles
Cook Medical - Reproductive Health Portfolio subsidiaries and ownership
Company hierarchySubsidiaries12 records
Cook Medical - Reproductive Health Portfolio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cook Medical - Reproductive Health Portfolio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cook Medical - Reproductive Health Portfolio
What does Cook Medical - Reproductive Health Portfolio do?
Cook Medical's Reproductive Health portfolio designed, manufactured, and sold assisted reproductive technology (ART) medical devices for IVF clinics and fertility centers. Core products included the MINC+ Benchtop Incubator (next-generation benchtop incubator with enhanced humidification and dish-tracking software), culture media, and devices for ovum aspiration, intrauterine insemination, and embryo transfer and manipulation. Sales were executed through regional sales teams and distribution partners serving Asia-Pacific markets.
Is Cook Medical - Reproductive Health Portfolio a public or private company?
Cook Medical - Reproductive Health Portfolio is a private company. It is classified as family owned and is currently operating.
When was Cook Medical - Reproductive Health Portfolio founded?
Cook Medical - Reproductive Health Portfolio was founded in 1963. It employs 5,001 to 10,000 people.
Where is Cook Medical - Reproductive Health Portfolio based?
Cook Medical - Reproductive Health Portfolio is headquartered in Bloomington, United States, in the North America region.
How does Cook Medical - Reproductive Health Portfolio make money?
One revenue line is on record: reproductive Health Medical Devices.
Who are Cook Medical - Reproductive Health Portfolio's main competitors?
Direct peers on record are Hamilton Thorne, Vitrolife, CooperSurgical, Genea Biomedx, Esco Medical, FUJIFILM Irvine Scientific, Kitazato Corporation and Rocket Medical. Broad incumbents are Merck KGaA (Sigma-Aldrich) and Smiths Medical.
Does Cook Medical - Reproductive Health Portfolio have an API?
No public API is recorded for Cook Medical - Reproductive Health Portfolio.
What industry is Cook Medical - Reproductive Health Portfolio in?
Cook Medical - Reproductive Health Portfolio's product category is IVF and Assisted Reproductive Technology Medical Devices. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers. Its NAICS code is 339113 and its SIC code is 3841.